Table 1.

TNF activation compromise in vivo multilineage reconstituting activity of NOD-SCID repopulating cells

CellsEEExpansion (d)Reconstitution
−TNF+TNF
Positive micePercent human engraftmentPositive micePercent human engraftment
Exp. 1 CD34+ 85 000 5-8 4/4 25  (6-25-34-36) 0/4 0.2  (0-0-0.3-0.5) 
Exp. 2 CD34+C D38 5 000 2/2 51  (23-79)   
  2 700-5 300   1/2 0-1.1 
Exp. 3 CD34+ 50 000 3/3 8  (0.3-5-18) 0/3 0.3  (0-0-0.9) 
Total    9/9 25 1/9 0.3 
Exp. 3 CD34+ 50 000 3/3 2  (0.1-1-5) 2/3 2  (0-2.5-3)  
Exp. 4 CD34+ 50 000 3/5 5  (0-0.1-0.2-0.3-23) 3/3 8  (0.2-3-21) 
Total    6/8 5/6 
CellsEEExpansion (d)Reconstitution
−TNF+TNF
Positive micePercent human engraftmentPositive micePercent human engraftment
Exp. 1 CD34+ 85 000 5-8 4/4 25  (6-25-34-36) 0/4 0.2  (0-0-0.3-0.5) 
Exp. 2 CD34+C D38 5 000 2/2 51  (23-79)   
  2 700-5 300   1/2 0-1.1 
Exp. 3 CD34+ 50 000 3/3 8  (0.3-5-18) 0/3 0.3  (0-0-0.9) 
Total    9/9 25 1/9 0.3 
Exp. 3 CD34+ 50 000 3/3 2  (0.1-1-5) 2/3 2  (0-2.5-3)  
Exp. 4 CD34+ 50 000 3/5 5  (0-0.1-0.2-0.3-23) 3/3 8  (0.2-3-21) 
Total    6/8 5/6 

CD34+ or CD34+CD38 CB cells were cultured for 5 to 8 days (experiments 1-3) or 2 days (experiments 3 and 4) in SF medium in KFT3 in the absence or presence of TNF. NOD-SCID mice were transplanted with the EEs of 50 000 to 85 000 CD34+ cells or 2700 to 5300 CD34+CD38 cells as indicated. Data are presented as number of mice positive for human reconstitution with both B and myeloid cells. Also shown is the percentage human engraftment (representing total human reconstitution independent of whether both myeloid and B cells were observed) of individual animals within each group.

Close Modal

or Create an Account

Close Modal
Close Modal